PB1888: TRIAL IN PROGRESS: PHASE 1B/2 STUDY OF PIVEKIMAB SUNIRINE (PVEK, IMGN632) IN COMBINATION WITH VENETOCLAX/AZACITIDINE OR MAGROLIMAB FOR PATIENTS WITH CD123-POSITIVE ACUTE MYELOID LEUKEMIA (AML)
Naval Daver,
Pau Montesinos,
Ahmed Aribi,
Giovanni Martinelli,
Eunice Wang,
Jessica Altman,
Gail Roboz,
Patrick Burke,
Roland Walter,
Kebede Benga,
Callum Sloss,
Kara Malcolm,
Patrick Zweidler-Mckay,
Kendra Sweet
Affiliations
Naval Daver
1 MD Anderson Cancer Center, Houston, United States
Pau Montesinos
2 Hospital Universitari i Politècnic La Fe, Valencia, Spain
Ahmed Aribi
3 City of Hope, Duarte, United States
Giovanni Martinelli
4 IRCCS Istituto Romagnolo per lo Studio dei Tumori “Dino Amadori” IRST S.r.l., Meldola, Italy
Eunice Wang
5 Roswell Park Comprehensive Cancer Center, Buffalo, United States
Jessica Altman
6 Northwestern University, Chicago, United States
Gail Roboz
7 Weill Cornell Medical College, New York, United States
Patrick Burke
8 University of Michigan, Ann Arbor, United States
Roland Walter
9 Fred Hutchinson Cancer Center, Seattle, United States
Kebede Benga
10 Mayo Clinic, Rochester, United States
Callum Sloss
11 ImmunoGen, Inc, Waltham, United States
Kara Malcolm
11 ImmunoGen, Inc, Waltham, United States
Patrick Zweidler-Mckay
11 ImmunoGen, Inc, Waltham, United States
Kendra Sweet
12 H. Lee Moffitt Cancer Center and Research Institute, Tampa, United States
